What is KALA BIO, Inc. Common Stock's Market Cap?

KALA BIO, Inc. Common Stock's Market Cap is $10.4M, based on as-reported figures from SEC (XBRL) filings.

What is KALA BIO, Inc. Common Stock's Revenue (TTM)?

KALA BIO, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is KALA BIO, Inc. Common Stock's Net Income (TTM)?

KALA BIO, Inc. Common Stock's Net Income (TTM) is -$10.1M, based on as-reported figures from SEC (XBRL) filings.

What is KALA BIO, Inc. Common Stock's EBITDA?

KALA BIO, Inc. Common Stock's EBITDA is -$20.7M, based on as-reported figures from SEC (XBRL) filings.

What is KALA BIO, Inc. Common Stock's Diluted EPS (TTM)?

KALA BIO, Inc. Common Stock's Diluted EPS (TTM) is -0.52, based on as-reported figures from SEC (XBRL) filings.

KALA BIO, Inc. Common Stock (KALA) Financial Statements

KALA BIO, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001V0GBM6

XNAS · usd

0.54▲ 0.03 (6.03%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close0.51

Day's Range0.49 – 0.55

52-Week Range0.07 – 20.60

Volume147.8K

Avg Volume476.8K

Share Statistics

Shares Outstanding

Employees6

ExchangeXNAS

Listed2017-07-20

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about KALA BIO, Inc. Common Stock (KALA)

What is KALA BIO, Inc. Common Stock's Market Cap?: KALA BIO, Inc. Common Stock's Market Cap is $10.4M, based on as-reported figures from SEC (XBRL) filings.
What is KALA BIO, Inc. Common Stock's Revenue (TTM)?: KALA BIO, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is KALA BIO, Inc. Common Stock's Net Income (TTM)?: KALA BIO, Inc. Common Stock's Net Income (TTM) is -$10.1M, based on as-reported figures from SEC (XBRL) filings.
What is KALA BIO, Inc. Common Stock's EBITDA?: KALA BIO, Inc. Common Stock's EBITDA is -$20.7M, based on as-reported figures from SEC (XBRL) filings.
What is KALA BIO, Inc. Common Stock's Diluted EPS (TTM)?: KALA BIO, Inc. Common Stock's Diluted EPS (TTM) is -0.52, based on as-reported figures from SEC (XBRL) filings.